Your question on iHub the other day. I wonder w
Post# of 145192
Quote:
I wonder what percentage of CCR5 leronlimab blocks. We know from HIV that leronlimab can be overwhelmed by a mass proliferation of CCR5 targets. It's possible that an overexpression of miR-455-5p to reduce the number of CCR5 targets combined with leronlimab may produce an even better outcome than leronlimab alone.
I found this from the latest poster.
![731608239_april1p1.jpg](https://investorshangout.com/images/MYImages/731608239_april1p1.jpg)
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)